Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hachiro Sugimoto

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Neoplasia (New York, N.Y.)|October 5, 2011
Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cellsOltea Sampetrean, Isako Saga, Masaya Nakanishi, et al.
Free Radical Biology & Medicine|July 4, 2012
Isolation, identification, and biological evaluation of Nrf2-ARE activator from the leaves of green perilla (Perilla frutescens var. crispa f. viridis)Yasuhiko Izumi, Atsuko Matsumura, Seiko Wakita, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitorsJun Takahashi, Ichiro Hijikuro, Takeshi Kihara, et al.
Bioorganic & Medicinal Chemistry|September 7, 2007
Synthesis and pharmacological profile of serofendic acids A and BTaro Terauchi, Naoki Asai, Takashi Doko, et al.
Journal of Neurochemistry|September 2, 2005
Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian ratsMasatoshi Inden, Yoshihisa Kitamura, Jun-Ichi Kondo, et al.
Journal of Alzheimer'S Disease : JAD|June 10, 2017
PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8Michiaki Okuda, Yuki Fujita, Ichiro Hijikuro, et al.
Plos One|February 7, 2015
PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivoMichiaki Okuda, Ichiro Hijikuro, Yuki Fujita, et al.
Journal of Neurochemistry|December 3, 2008
N-cadherin-based adhesion enhances Abeta release and decreases Abeta42/40 ratioKengo Uemura, Christina M Lill, Mary Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Isolation of a diterpenoid substance with potent neuroprotective activity from fetal calf serumToshiaki Kume, Naoki Asai, Hiroyuki Nishikawa, et al.
Nature Communications|December 17, 2015
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groupsYoshiyuki Soeda, Misato Yoshikawa, Osborne F X Almeida, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Neoplasia (New York, N.Y.)|October 5, 2011
Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cellsOltea Sampetrean, Isako Saga, Masaya Nakanishi, et al.
Free Radical Biology & Medicine|July 4, 2012
Isolation, identification, and biological evaluation of Nrf2-ARE activator from the leaves of green perilla (Perilla frutescens var. crispa f. viridis)Yasuhiko Izumi, Atsuko Matsumura, Seiko Wakita, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitorsJun Takahashi, Ichiro Hijikuro, Takeshi Kihara, et al.
Bioorganic & Medicinal Chemistry|September 7, 2007
Synthesis and pharmacological profile of serofendic acids A and BTaro Terauchi, Naoki Asai, Takashi Doko, et al.
Journal of Neurochemistry|September 2, 2005
Serofendic acid prevents 6-hydroxydopamine-induced nigral neurodegeneration and drug-induced rotational asymmetry in hemi-parkinsonian ratsMasatoshi Inden, Yoshihisa Kitamura, Jun-Ichi Kondo, et al.
Journal of Alzheimer'S Disease : JAD|June 10, 2017
PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8Michiaki Okuda, Yuki Fujita, Ichiro Hijikuro, et al.
Plos One|February 7, 2015
PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivoMichiaki Okuda, Ichiro Hijikuro, Yuki Fujita, et al.
Journal of Neurochemistry|December 3, 2008
N-cadherin-based adhesion enhances Abeta release and decreases Abeta42/40 ratioKengo Uemura, Christina M Lill, Mary Banks, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Isolation of a diterpenoid substance with potent neuroprotective activity from fetal calf serumToshiaki Kume, Naoki Asai, Hiroyuki Nishikawa, et al.
Nature Communications|December 17, 2015
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groupsYoshiyuki Soeda, Misato Yoshikawa, Osborne F X Almeida, et al.
Pageof 9